The European biotechnology landscape is advancing at breakneck speed, driven by cross-border collaborations, novel therapeutics, and advanced AI applications. Yet, the drug discovery and development process remains hindered by the complexity and scale of biological data. From multi-omics research to translational medicine, valuable biomedical data is often trapped in siloed legacy systems, unstructured formats, or fragmented regional databases.

At Elucidata, we help global biopharma companies break free from these data bottlenecks. Our platform, Polly, and our specialized Research Informatics solutions provide a unified foundation for your entire R&D lifecycle. We automate the ingestion, curation, and harmonization of complex multi-modal data, creating a single source of truth that powers next-generation biotech innovations.

Whether you are looking to optimize cross-species target discovery, integrate massive clinico-genomic datasets, or prepare your R&D data for predictive foundation models, we turn your "messy" biological data into a highly structured asset that accelerates candidate selection and drastically reduces manual effort.

Meet our team at BIO-Europe Spring 2026 in Lisbon to learn how we are helping top biopharmaceutical companies cut manual data processing time, build robust Knowledge Graphs, and bring life-saving therapies to market faster.